Lyell is a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies.
Lyell is a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies. We are seeking a Senior Director, Medical Affairs, Solid Tumors to lead the development and execution of US medical strategies for solid tumors, with an initial focus on metastatic colorectal cancer (mCRC).
Lyell is a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies.
Lyell Immunopharma